Lipid update Flashcards

1
Q

Is there any advantage in giving thiazide diuretic to someone with a beta blockers with a BP of 140/80?

A

Yes - add thiazide diuretic intensively to reduce to 120/80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Intensive management of blood pressure

A

Intensive lifestyle modification
Aspirin
High dose statin
Optimal blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Example of statin and its dose

A

Atorvastatin 40-80mg od

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What do you call it when patients are given a statin and told they might get muscle pain and they do actually get muscle pain?

A

nocibec event

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is PCSK9?

A

It controls the rate of LDL receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is PCSK9?

A

It controls the rate of LDL receptor by breaking it down

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give an example of a PCSK9 inhibitor? What does it do?

A

Evolocumab - stops the breakdown of LDL receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How effective was adding PCSK9 in lowering LDL levels?

A

Reduces MI chance, but doesn’t reduce the chance of death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Compare adding PCSK9 to statin with adding thiazide to BB

A

PCSK9 was marketed for those with statin intolerance

Problem is that it is SO EXPENSIVE compared to thiazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How long does it take to have good blood glucose control?

A

15 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the legacy effect?

A

If you have tight control when you have patent coronary arteries, the benefits persist even if you then become less well control. Basically good control early on in your disease is excellent. The benefits exist for at least 30 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

UKPDS study - intensive T2DM therapy findings

A

20 years intervention

Further 10 ears follow-up showed that the study group benefited even after the study was over

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What happened when Rosiglitazone was given to patients? What was the study called and who was it done by and done on?

A

Tight blood glucose control in later stages of life caused more death. It has been banned.

Thiazolidinedione

ACCORD study done by pharma companies - they took patietns who had already had 1 vascular event.

After this,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The first trial

A

DCCT - diabetes control and complications trial

Good control improves everything

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does SGLT 2 inhibitors work

A

GLYCOSURIC DRUG

They make you pee our glucose as they stop glucose reabsorption in the PCT

You loose BP as it is a diuretic
and you loose weight because you’re losing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does MACE mean?

A

Major adverse cardiac events

17
Q

Name an SGLT2 inhib and its effectiveness

A

Empaglifozin - the cardiovascular death risk reduces within six months!

18
Q

What was the study on SGLT2 inhibitors called?

A

EMPA-REG study

19
Q

What is the one side effect of SGLT2 inhibitors?

A

More likely to get UTI

20
Q

Empaglifozin effects on kidneys

A

Risk of nephropathy, need for dialysis and doubling serum-creatine dropped

21
Q

What do you see in terms of effects of empaglifozin?

A

Initially it makes your eGFR worse but as you persist, it has a renoprotective effect (like with ACE-inhibitors)

22
Q

Overall, what is the effect of empaglifozin?

A

Reduces blood sugars
Reduces CV risk
Reduces renal risk

23
Q

Name a GLP-1 analogue

A

Liraglutide

24
Q

What’s the problem with GLP-1 analogues?

A

they are a peptide so need to be taken

25
Q

Key diabetes drugs

A

Metformins
SGLT2
GLP-1 receptor agonist